Study to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's Disease (TargetTau-1)

July 21, 2025 updated by: Bristol-Myers Squibb

A Randomized, Double-blind, Placebo-controlled, Global Proof-of-concept Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Participants With Early Alzheimer's Disease (TargetTau-1)

The purpose of this study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's Disease.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Active, not recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
310

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.
  • Name: First line of the email MUST contain NCT # and Site #.

Study Contact Backup

  • Name: BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
  • Phone Number: 855-907-3286
  • Email: Clinical.Trials@bms.com

Study Locations

  • Australia
    • New South Wales
      • East Gosford, New South Wales, Australia, 2250
        • Local Institution - 0111
      • Macquarie Park, New South Wales, Australia, 2113
        • Local Institution - 0170
    • Queensland
      • Griffith University, Queensland, Australia, 4222
        • Local Institution - 0116
    • Victoria
      • Carlton North, Victoria, Australia, 3053
        • Local Institution - 0115
      • Ivanhoe, Victoria, Australia, 3081
        • Local Institution - 0093
      • Malvern, Victoria, Australia, 3144
        • Local Institution - 0001
      • Melbourne, Victoria, Australia, 03181
        • Local Institution - 0125
      • Parkville, Victoria, Australia, 3050
        • Local Institution - 0147
    • Western Australia
      • Nedlands, Western Australia, Australia, 6009
        • Local Institution - 0094
  • Belgium
      • Brussels, Belgium, 1200
        • Local Institution - 0097
      • Leuven, Belgium, 3000
        • Local Institution - 0076
    • Brussel
      • Antwerpen, Brussel, Belgium, 2018
        • Local Institution - 0175
    • Brussels
      • Anderlecht, Brussels, Belgium, 1070
        • Local Institution - 0122
    • VWV
      • Kortrijk, VWV, Belgium, 8500
        • Local Institution - 0082
  • Canada
      • Quebec, Canada, G3K 2P8
        • Local Institution - 0053
    • Ontario
      • Ottawa, Ontario, Canada, K1Z 8R7
        • Local Institution - 0112
      • Toronto, Ontario, Canada, M3B 2S7
        • Local Institution - 0047
      • Toronto, Ontario, Canada, M5T 2S8
        • Local Institution - 0044
      • Toronto, Ontario, Canada, M6A 2E1
        • Local Institution - 0109
    • Quebec
      • Greenfield Park, Quebec, Canada, J4V 2J2
        • Local Institution - 0113
      • Montreal, Quebec, Canada, H4A 3T2
        • Local Institution - 0248
  • Japan
      • Chuo-Ku, Japan, 104-0031
        • Local Institution - 0226
      • Himeji-shi, Japan, 670-8560
        • Local Institution - 0190
      • Kasukabe-Shi, Japan, 344-0036
        • Local Institution - 0188
      • Kodaira-Shi, Japan, 187-8551
        • Local Institution - 0179
      • Musashimurayama-Shi, Japan, 208-0022
        • Local Institution - 0221
      • Musashino-shi, Japan, 180-8610
        • Local Institution - 0220
      • Nagoya-Shi, Japan, 451-0052
        • Local Institution - 0180
      • Obu, Japan, 474-8511
        • Local Institution - 0232
      • Osaka-shi, Japan, 545-8586
        • Local Institution - 0178
      • Tachikawa-Shi, Japan, 190-0022
        • Local Institution - 0240
      • Takatsuki-Shi, Japan, 569-1192
        • Local Institution - 0239
      • Toyonaka-Shi, Japan, 560-0004
        • Local Institution - 0189
    • Aichi
      • Nagoya-Shi, Aichi, Japan, 4570818
        • Local Institution - 0181
    • Ibaraki
      • Toride-Shi, Ibaraki, Japan, 302-0004
        • Local Institution - 0227
    • Okayama
      • Kurashiki-Shi, Okayama, Japan, 710-0813
        • Local Institution - 0186
    • Osaka
      • Hirakata-Shi, Osaka, Japan, 573-1121
        • Local Institution - 0242
      • Osaka-shi, Osaka, Japan, 556-0015
        • Local Institution - 0253
    • Tokyo
      • Bunkyo-Ku, Tokyo, Japan, 1130034
        • Local Institution - 0185
      • Hachioji-Shi, Tokyo, Japan, 192-0071
        • Local Institution - 0218
      • Setagaya-Ku, Tokyo, Japan, 1588531
        • Local Institution - 0184
  • Korea, Republic of
      • Gwangjingu, Korea, Republic of, 143-729
        • Local Institution - 0110
      • Incheon, Korea, Republic of, 21565
        • Local Institution - 0050
      • Junggu, Korea, Republic of, 22332
        • Local Institution - 0114
    • Seoul
      • Songpa-gu, Seoul, Korea, Republic of, 138-736
        • Local Institution - 0117
  • Singapore
      • Singapore, Singapore, 119228
        • Local Institution - 0091
  • Spain
      • Barcelona, Spain, 08035
        • Local Institution - 0171
      • Barcelona, Spain, 08003
        • Local Institution - 0096
      • Barcelona, Spain, 08041
        • Local Institution - 0172
    • B
      • Barcelona, B, Spain, 08036
        • Local Institution - 0158
    • CT
      • Sant Cugat Del Vallès, CT, Spain, 08195
        • Local Institution - 0054
    • L
      • Lleida, L, Spain, 25006
        • Local Institution - 0231
  • Sweden
    • M
      • Malmo, M, Sweden, 212 24
        • Local Institution - 0167
  • United Kingdom
    • LND
      • Enfield, LND, United Kingdom, EN3 4GS
        • Local Institution - 0121
      • London, LND, United Kingdom, EC2Y 8EA
        • Local Institution - 0252
    • SOM
      • Bath, SOM, United Kingdom, BA1 3NG
        • Local Institution - 0247
    • Surrey
      • Chertsey, Surrey, United Kingdom, KT16 9AU
        • Local Institution - 0089
  • United States
    • Arizona
      • Chandler, Arizona, United States, 85226-3732
        • Local Institution - 0068
      • Gilbert, Arizona, United States, 85297-0441
        • Local Institution - 0102
      • Phoenix, Arizona, United States, 85004
        • Local Institution - 0019
      • Scottsdale, Arizona, United States, 85253
        • Local Institution - 0018
      • Scottsdale, Arizona, United States, 85258-4595
        • Local Institution - 0026
      • Tucson, Arizona, United States, 85718-6522
        • Local Institution - 0077
      • Tucson, Arizona, United States, 85718-6632
        • Local Institution - 0038
    • California
      • Encino, California, United States, 91316-1511
        • Local Institution - 0164
      • Fullerton, California, United States, 92835-1040
        • Local Institution - 0139
      • Irvine, California, United States, 92614-9403
        • Local Institution - 0191
      • Long Beach, California, United States, 90804-2128
        • Local Institution - 0234
      • Los Alamitos, California, United States, 90720-3589
        • Local Institution - 0142
      • Napa, California, United States, 94558-2415
        • Local Institution - 0037
      • Sacramento, California, United States, 95816
        • Local Institution - 0209
      • San Francisco, California, United States, 94143-2350
        • Local Institution - 0052
      • Santa Ana, California, United States, 92705-8675
        • Local Institution - 0137
      • Sherman Oaks, California, United States, 91403-2131
        • Local Institution - 0046
    • Connecticut
      • Danbury, Connecticut, United States, 06810-4088
        • Local Institution - 0106
      • New Haven, Connecticut, United States, 06510
        • Local Institution - 0148
      • New Haven, Connecticut, United States, 06511-5249
        • Local Institution - 0056
      • Stamford, Connecticut, United States, 06905-1206
        • Local Institution - 0153
    • Florida
      • Altamonte Springs, Florida, United States, 32714-2436
        • Local Institution - 0022
      • Atlantis, Florida, United States, 33462-6631
        • Local Institution - 0048
      • Boca Raton, Florida, United States, 33428-2236
        • Local Institution - 0228
      • Boca Raton, Florida, United States, 33487-3626
        • Local Institution - 0250
      • Bradenton, Florida, United States, 34205
        • Local Institution - 0224
      • Clermont, Florida, United States, 34711-5933
        • Local Institution - 0020
      • Daytona Beach, Florida, United States, 32117-5532
        • Local Institution - 0009
      • Fort Myers, Florida, United States, 33912-4302
        • Local Institution - 0213
      • Greenacres City, Florida, United States, 33467
        • Local Institution - 0059
      • Hialeah, Florida, United States, 33012-4170
        • Local Institution - 0207
      • Hialeah, Florida, United States, 33015-5110
        • Local Institution - 0212
      • Hialeah, Florida, United States, 33016-1814
        • Local Institution - 0198
      • Lady Lake, Florida, United States, 32159
        • Local Institution - 0151
      • Lakeland, Florida, United States, 33805-2208
        • Local Institution - 0146
      • Maitland, Florida, United States, 32751
        • Local Institution - 0143
      • Maitland, Florida, United States, 32751-3320
        • Local Institution - 0192
      • Merritt Island, Florida, United States, 32952-3616
        • Local Institution - 0027
      • Miami, Florida, United States, 33175-3598
        • Local Institution - 0156
      • Miami, Florida, United States, 33032
        • Local Institution - 0203
      • Miami, Florida, United States, 33122-1335
        • Local Institution - 0058
      • Miami, Florida, United States, 33125-4719
        • Local Institution - 0034
      • Miami, Florida, United States, 33126
        • Local Institution - 0211
      • Miami, Florida, United States, 33133-4231
        • Local Institution - 0195
      • Miami, Florida, United States, 33135-2957
        • Local Institution - 0014
      • Miami, Florida, United States, 33135-2968
        • Local Institution - 0005
      • Miami, Florida, United States, 33135-4759
        • Local Institution - 0208
      • Miami, Florida, United States, 33135
        • Local Institution - 0013
      • Miami, Florida, United States, 33137-2706
        • Local Institution - 0008
      • Miami, Florida, United States, 33144
        • Local Institution - 0199
      • Miami, Florida, United States, 33155-4630
        • Local Institution - 0206
      • Miami, Florida, United States, 33155-6540
        • Local Institution - 0176
      • Miami, Florida, United States, 33166-2710
        • Local Institution - 0071
      • Miami, Florida, United States, 33176-2151
        • Local Institution - 0249
      • Miami, Florida, United States, 33176-7947
        • Local Institution - 0039
      • Miami, Florida, United States, 33176
        • Local Institution - 0225
      • Miami Springs, Florida, United States, 33166-7225
        • Local Institution - 0197
      • Naples, Florida, United States, 34105
        • Local Institution - 0217
      • New Port Richey, Florida, United States, 34652-4020
        • Local Institution - 0017
      • Ocala, Florida, United States, 34471
        • Local Institution - 0144
      • Orlando, Florida, United States, 32806-8521
        • Local Institution - 0202
      • Orlando, Florida, United States, 32807
        • Local Institution - 0219
      • Orlando, Florida, United States, 32819-8031
        • Local Institution - 0035
      • Orlando, Florida, United States, 32832
        • Local Institution - 0238
      • Port Orange, Florida, United States, 32127-5170
        • Local Institution - 0210
      • Sarasota, Florida, United States, 34239-3228
        • Local Institution - 0204
      • Stuart, Florida, United States, 34997-6405
        • Local Institution - 0136
      • Stuart, Florida, United States, 34997-5765
        • Local Institution - 0012
      • Tampa, Florida, United States, 33607-6210
        • Local Institution - 0200
      • Tampa, Florida, United States, 33607-6616
        • Local Institution - 0080
      • Tampa, Florida, United States, 33609-4049
        • Local Institution - 0087
      • Tampa, Florida, United States, 33613-4808
        • Local Institution - 0042
      • Viera, Florida, United States, 32940-7948
        • Local Institution - 0194
      • Wellington, Florida, United States, 33414-9320
        • Local Institution - 0011
      • West Palm Beach, Florida, United States, 33409-6611
        • Local Institution - 0149
      • West Palm Beach, Florida, United States, 33407-3234
        • Local Institution - 0223
      • Windermere, Florida, United States, 34786-8919
        • Local Institution - 0029
      • Winter Park, Florida, United States, 32792
        • Local Institution - 0154
      • Winter Park, Florida, United States, 32789-1848
        • Local Institution - 0101
    • Georgia
      • Columbus, Georgia, United States, 31909-1692
        • Local Institution - 0105
    • Illinois
      • Chicago, Illinois, United States, 60611-2818
        • Local Institution - 0236
      • Chicago, Illinois, United States, 60640-2831
        • Local Institution - 0021
      • Elk Grove Village, Illinois, United States, 60007-3362
        • Local Institution - 0161
      • Gurnee, Illinois, United States, 60031
        • Local Institution - 0003
      • Park Ridge, Illinois, United States, 60068
        • Local Institution - 0145
      • Springfield, Illinois, United States, 62702-4968
        • Local Institution - 0081
    • Massachusetts
      • Boston, Massachusetts, United States, 02116
        • Local Institution - 0235
      • Boston, Massachusetts, United States, 02131-2515
        • Local Institution - 0025
      • Braintree, Massachusetts, United States, 02184
        • Local Institution - 0015
      • Foxboro, Massachusetts, United States, 02035-1309
        • Local Institution - 0174
      • Methuen, Massachusetts, United States, 01844-5864
        • Local Institution - 0118
      • Newton, Massachusetts, United States, 02459-3328
        • Local Institution - 0040
      • Plymouth, Massachusetts, United States, 02360-7223
        • Local Institution - 0120
      • Watertown, Massachusetts, United States, 02472-4153
        • Local Institution - 0045
    • New Hampshire
      • Portsmouth, New Hampshire, United States, 03801-6822
        • Local Institution - 0119
    • New Jersey
      • Princeton, New Jersey, United States, 08540-2859
        • Local Institution - 0031
      • Toms River, New Jersey, United States, 08755-5043
        • Local Institution - 0062
    • New York
      • Albany, New York, United States, 12208-3464
        • Local Institution - 0060
      • Amherst, New York, United States, 14226-1727
        • Local Institution - 0157
      • Manhasset, New York, United States, 11030-3816
        • Local Institution - 0061
      • New York, New York, United States, 10029-5611
        • Local Institution - 0205
      • New York, New York, United States, 10029-5611
        • Local Institution - 0214
      • New York, New York, United States, 10029-6504
        • Local Institution - 0104
      • New York, New York, United States, 10032-3726
        • Local Institution - 0133
    • North Carolina
      • Matthews, North Carolina, United States, 28105-8336
        • Local Institution - 0043
    • Ohio
      • Dayton, Ohio, United States, 45459-4296
        • Local Institution - 0215
      • Independence, Ohio, United States, 44131
        • Local Institution - 0155
    • Pennsylvania
      • Plymouth Meeting, Pennsylvania, United States, 19462-7401
        • Local Institution - 0023
    • Rhode Island
      • East Providence, Rhode Island, United States, 02914
        • Local Institution - 0024
      • Providence, Rhode Island, United States, 02906-4800
        • Local Institution - 0163
    • Tennessee
      • Cordova, Tennessee, United States, 38018-4254
        • Local Institution - 0132
      • Franklin, Tennessee, United States, 37067-5922
        • Local Institution - 0140
      • Nashville, Tennessee, United States, 37212
        • Local Institution - 0222
    • Texas
      • Austin, Texas, United States, 78757-8046
        • Local Institution - 0069
      • Beaumont, Texas, United States, 77702
        • Local Institution - 0033
      • Dallas, Texas, United States, 75231-4316
        • Local Institution - 0051
      • Houston, Texas, United States, 77074-1812
        • Local Institution - 0016
    • Virginia
      • Fairfax, Virginia, United States, 22031-5216
        • Local Institution - 0196
      • Richmond, Virginia, United States, 23294
        • Local Institution - 0168

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria

  • Mild cognitive impairment (MCI) due to Alzheimer's disease (AD) or mild AD dementia consistent with the National Institute on Aging and the Alzheimer's Association (NIA-AA) core clinical criteria.
  • Global Clinical Dementia Rating (CDR) score of 0.5 to 1.0 and a CDR-Memory Box score of 0.5 and greater at screening and Baseline.
  • Evidence of AD pathology.
  • Objective impairment in episodic memory as indicated by at least 1 standard deviation below age-adjusted mean in the Wechsler Memory Scale IV-Logical Memory Subtest II (WMS-IV LM II).
  • Mini Mental Status Examination (MMSE) score ≥ 20 to 28 (inclusive).

Exclusion Criteria

  • Any evidence of a condition that may affect cognition other than AD.
  • Contraindications to PET imaging.
  • Inability to tolerate or contraindication to magnetic resonance imaging.
  • Any serious medical condition that could, in the opinion of the investigator, affect the participant's safety or interfere with study assessments.
  • Geriatric Depression Scale (GDS) score greater than or equal to 8 at screening.
  • Other protocol-defined Inclusion/Exclusion criteria apply.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Placebo Comparator: Placebo
Other: Placebo
Specified dose on specified days
Experimental: BMS-986446 Dose A
Drug: BMS-986446
Specified dose on specified days
Experimental: BMS-986446 Dose B
Drug: BMS-986446
Specified dose on specified days

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Time Frame
Change from baseline in brain tau deposition as measured by tau positron emission tomography (PET)
Time Frame: At week 76
At week 76

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Time Frame
Change from baseline in Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) score
Time Frame: At week 76
At week 76
Change from baseline in integrated Alzheimer's Disease Rating Scale (iADRS) score
Time Frame: At week 76
At week 76
Change from baseline in Alzheimer's Disease Assessment Scale-Cognitive subscale (ADASCog14) score
Time Frame: At week 76
At week 76
Change from baseline in Alzheimer's Disease Cooperative Study-instrumental Activities of Daily Living scale (ADCS-iADL) score
Time Frame: At week 76
At week 76
Change from baseline in Mini Mental State Examination (MMSE) score
Time Frame: At week 76
At week 76

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Bristol-Myers Squibb

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Study Director: Bristol-Myers Squibb, Bristol-Myers Squibb

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
March 20, 2024

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 18, 2027

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 18, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
February 13, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
February 13, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
February 20, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
July 24, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 21, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
July 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • CN008-0003
  • U1111-1290-3539 (Registry Identifier: WHO)
  • 2023-504840-32 (Other Identifier: EU CTR)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

BMS will provide access to individual anonymized participant data upon request from qualified researchers, and subject to certain criteria.

Additional information regarding Bristol Myers Squibb's data sharing policy and process can be found at:

https://www.bms.com/researchers-and-partners/clinical-trials-and-research/disclosurecommitment.html

IPD Sharing Time Frame

See Plan Description

IPD Sharing Access Criteria

See Plan Description

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

Yes

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings